Calls for urgent crackdown on illegal backyard solariums
7 March 2018
The reported proliferation of illegal commercial solariums is costing lives and requires urgent government intervention.
Melanoma Institute Australia research was integral in the banning of commercial solariums across Australia after showing a clear link between solarium use and melanoma. The ban fell short of including private solariums.
Following last night’s report on 7:30, which detailed a thriving underground commercial solarium industry, MIA is calling on government agencies to take immediate action.
‘There is conclusive evidence linking solarium use with an increased risk of melanoma,’ said Professor Graham Mann from Melanoma Institute Australia.
"Our research focused on patients under 40, and it was really clear that those who'd had more than 10 solarium visits in their life had up to a seven-times greater risk of developing melanoma.
‘Illegal backyard solarium businesses are costing lives and urgent action needs to be taken now to shut them down,’ he said.
One Australian dies every five hours from melanoma. It is the most common cancer affecting 15 to 39 year olds and kills more 20 to 39 year olds than any other cancer.
Particularly disturbing were comments on 7:30 from young women who are blatantly ignoring the risks and continuing to use solariums.
‘At a time when families across Australia are taking part in Melanoma March events in memory of loved ones they have lost to melanoma, it was confronting and sad to see young women choosing to put their health at risk for a tan,’ Professor Mann said.
"The research is really clear that whatever type of solarium you're using, in a home or a backyard commercial operation - none of them are safe.
‘No tan is worth dying for, and it is time for authorities across the country to step up their prosecution of these illegal solarium operators.
‘Ideally, we’d like to see governments take it one step further and ban all solariums, including for private use.
‘The health risks are just too high.’
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.